IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity

International Immunology

Volumn 26, Issue 11, 2014, Pages 585-595

  Umehara, Hisanori ^a,b   Nakajima, Akio ^a   Nakamura, Takuji ^a   Kawanami, Takafumi ^a   Tanaka, Masao ^a   Dong, Lingli ^c   Kawano, Mitsuhiro ^d  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

IgG4; Regulatory T cell; Th2; Toll like receptor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AORTA ANEURYSM; AORTITIS; AUTOIMMUNE PANCREATITIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPLEMENT ACTIVATION; DACRYOCYSTITIS; DENDRITIC CELL; EYE DISEASE; FIBROSIS; HASHIMOTO DISEASE; HUMAN; HYPOCOMPLEMENTEMIA; HYPOPHYSITIS; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOGLOBULIN STRUCTURE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTERSTITIAL NEPHRITIS; INTERSTITIAL PNEUMONIA; KIDNEY DISEASE; LUNG DISEASE; LYMPHADENOPATHY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MASTITIS; MEDICAL TERMINOLOGY; MENINGITIS; NONHUMAN; ORBIT TUMOR; ORBITAL MYOSITIS; PANCREATITIS; PAROTITIS; PERIARTERITIS; PLASMA CELL; PLASMA CELL GRANULOMA; PROSTATITIS; PSEUDOLYMPHOMA; REGULATORY T LYMPHOCYTE; REVIEW; SALIVARY GLAND DISEASE; SCLEROSING CHOLANGITIS; SIALOADENITIS; SKIN DISEASE; T LYMPHOCYTE; THYROID DISEASE; THYROIDITIS; B LYMPHOCYTE; CELL COMMUNICATION; GENE REARRANGEMENT; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; B-LYMPHOCYTES; CELL COMMUNICATION; FIBROSIS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G;

EID: 84911449666     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxu074     Document Type: Review

References (94)

1. Umehara, H., Okazaki, K., Masaki, Y. et al. 2012. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod. Rheumatol. 22:1.
2. Stone, J. H., Zen, Y. and Deshpande, V. 2012. IgG4-related disease. N. Engl. J. Med. 366:539.
3. Hamano, H., Kawa, S., Horiuchi, A. et al. 2001. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344:732.
4. Deshpande, V., Zen, Y., Chan, J. K. et al. 2012. Consensus statement on the pathology of IgG4-related disease. Mod. Pathol. 25:1181.
5. Yamamoto, M., Ohara, M., Suzuki, C. et al. 2004. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand. J. Rheumatol. 33:432.
6. Masaki, Y., Dong, L., Kurose, N. et al. 2009. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann. Rheum. Dis. 63:1310.
7. Okazaki, K., Uchida, K., Koyabu, M., Miyoshi, H. and Takaoka, M. 2011. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J. Gastroenterol. 46:277.
8. Dahlgren, M., Khosroshahi, A., Nielsen, G. P., Deshpande, V. and Stone, J. H. 2010. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. 62:1312.
9. Zen, Y., Inoue, D., Kitao, A. et al. 2009. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am. J. Surg. Pathol. 33:1886.
10. Inoue, D., Zen, Y., Abo, H. et al. 2009. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 251:260.
11. Saeki, T., Saito, A., Yamazaki, H. et al. 2007. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin. Exp. Nephrol. 11:168.
12. Saeki, T., Nishi, S., Imai, N. et al. 2010. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 78:1016.
13. Sato, Y., Kojima, M., Takata, K. et al. 2009. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod. Pathol. 22:589.
14. Sato, Y., Notohara, K., Kojima, M., Takata, K., Masaki, Y. and Yoshino, T. 2010. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol. Int. 60:247.
15. Hamano, H., Kawa, S., Ochi, Y. et al. 2002. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359:1403.
16. Zen, Y., Onodera, M., Inoue, D. et al. 2009. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am. J. Surg. Pathol. 33:1833.
17. Stone, J. H., Khosroshahi, A., Hilgenberg, A., Spooner, A., Isselbacher, E. M. and Stone, J. R. 2009. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum. 60:3139.
18. Umehara, H. 2010. The Reports of the Grant from the Intractable Disease, Health and Labor Science Research Grants from the Ministry of Health, Labor and Welfare(H21-Nanchi-Ippann-112, representative Umehara H) [in Japanese]. Ministry of Health, Labor and Welfare, Japan.
19. Kamisawa, T., Nakajima, H., Egawa, N., Funatan, N., Tsuruta, K. and Okamoto, A. 2006. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 6:132.
20. Kamisawa, T., Funata, N. and Hayashi, Y. 2004. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am. J. Surg. Pathol. 28:1114.
21. Yamamoto, M., Takahashi, H., Hasebe, K. et al. 2009. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome-expansion of SIPS to the territory of Castleman's disease. Rheumatology 48:860.
22. Stone, J. H., Khosroshahi, A., Deshpande, V. et al. 2012. IgG4- related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum. 64:3061.
23. Masaki, Y., Sugai, S. and Umehara, H. 2010. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J. Rheumatol. 37:1380.
24. Shimosegawa, T., Chari, S. T., Frulloni, L. et al. 2011. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology Pancreas. 40:352.
25. Ohara, H., Okazaki, K., Tsubouchi, H. et al. 2012. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis. 2012. J. Hepatobiliary Pancreat Sci. 19:536.
26. Kawano, M., Saeki, T., Nakashima, H. et al. 2011. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin. Exp. Nephrol. 15:615.
27. Umehara, H., Okazaki, K., Masaki, Y. et al. 2011. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod. Rheumatol. 22:21.
28. Yamamoto, M., Takahashi, H., Ohara, M. et al. 2006. A case of Mikulicz's disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand. J. Rheumatol. 35:410.
29. Yamamoto, M., Takahashi, H., Sugai, S. and Imai, K. 2005. Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy). Autoimmun. Rev. 4:195.
30. Sarles, H., Sarles, J. C., Muratore, R. and Guien, C. 1961. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am. J. Dig. Dis. 6:688.
31. Kawaguchi, K., Koike, M., Tsuruta, K., Okamoto, A., Tabata, I. and Fujita, N. 1991. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum. Pathol. 22:387.
32. Okazaki, K., Uchida, K., Miyoshi, H., Ikeura, T., Takaoka, M. and Nishio, A. 2011. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin. Rev. Allergy Immunol. 41:126.
33. Uchiyama-Tanaka, Y., Mori, Y., Kimura, T. et al. 2004. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am. J. Kidney Dis. 43:e18.
34. Takeda, S., Haratake, J., Kasai, T., Takaeda, C. and Takazakura, E. 2004. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol. Dial. Transplant. 19:474.
35. Saeki, T., Imai, N., Ito, T., Yamazaki, H. and Hishi, S. 2009. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin. Nephrol. 2:173.
36. Takato, K., Yasui, M., Ichikawa, Y. et al. 2008. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern. Med. 47:291.
37. Li, Y., Bai, Y., Liu, Z. et al. 2009. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol. Int. 59:636.
38. Kakudo, K., Li, Y., Hirokawa, M. and Ozaki, T. 2011. Diagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease. Pathol. Int. 61:175.
39. Kojima, M., Hirokawa, M., Kuma, H. et al. 2010. Distribution of IgG4- and/or IgG-positive plasma cells in Hashimoto's thyroiditis: an immunohistochemical study. Pathobiology 77:267.
40. Kasashima, S. and Zen, Y. 2011. IgG4-related inflammatory abdominal aortic aneurysm. Curr. Opin. Rheumatol. 23:18.
41. h2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45:1538.
42. h2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod. Rheumatol. 18:86.
43. h2 and regulatory immune reactions contributes to IgG4 production and the initiation of Mikulicz's disease. Arthritis Rheum. 64:254.
44. Aparisi, L., Farre, A., Gomez-Cambronero, L. et al. 2005. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54:703.
45. Okazaki, K., Uchida, K. and Fukui, T. 2008. Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J. Gastroenterol. 43:409.
46. Guarneri, F., Guarneri, C. and Benvenga, S. 2005. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J. Cell. Mol. Med. 9:741.
47. Frulloni, L., Lunardi, C., Simone, R. et al. 2009. Identification of a novel antibody associated with autoimmune pancreatitis. N. Engl. J. Med. 361:2135.
48. Siddiquee, Z., Zane, N. A., Smith, R. N. and Stone, J. R. 2012. Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease. Cardiovasc. Pathol. 21:470.
49. Kawano, M., Yamada, K., Kakuchi, Y. et al. 2009. A case of immunoglobulin G4-related chronic sclerosing sialadenitis and dacryoadenitis associated with tuberculosis. Mod. Rheumatol. 19:87.
50. Akitake, R., Watanabe, T., Zaima, C. et al. 2010. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 59:542.
51. Aalberse, R. C. and Schuurman, J. 2002. IgG4 breaking the rules. Immunology 105:9.
52. Schuurman, J., Perdok, G. J., Gorter, A. D. and Aalberse, R. C. 2001. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol. Immunol. 38:1.
53. van der Neut Kolfschoten, M., Schuurman, J., Losen, M. et al. 2007. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317:1554.
54. van der Zee, J. S., van Swieten, P. and Aalberse, R. C. 1986. Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 64:415.
55. van der Zee, J. S., van Swieten, P. and Aalberse, R. C. 1986. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J. Immunol. 137:3566.
56. Aalberse, R. C., van der Gaag, R. and van Leeuwen, J. 1983. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130:722.
57. Nanda, A., O'Connor, M., Anand, M. et al. 2004. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J. Allergy Clin. Immunol. 114:1339.
58. Hussain, A., Pankhurst, T., Goodall, M. et al. 2009. Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcg receptors. Immunology 128:236.
59. Plomp, J. J., Huijbers, M. G., van der Maarel, S. M. and Verschuuren, J. J. 2012. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Ann. N. Y. Acad Sci. 1275:114.
60. Huijbers, M. G., Zhang, W., Klooster, R. et al. 2013. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc. Natl Acad. Sci. USA 110:20783.
61. Gniadecki, R. 2006. Desmoglein autoimmunity in the pathogenesis of pemphigus. Autoimmunity 39:541.
62. Cerutti, A., Puga, I. and Cols, M. 2011. Innate control of B cell responses. Trends Immunol. 32:202.
63. Litinskiy, M. B., Nardelli, B., Hilbert, D. M. et al. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822.
64. Sakuma, H., Okumura, F., Miyabe, S. et al. 2010. Analysis of VH gene rearrangement and somatic hypermutation in Sjogren's syndrome and IgG4-related sclerosing sialadenitis. Scand. J. Immunol. 72:44.
65. Miyoshi, H., Uchida, K., Taniguchi, T. et al. 2008. Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas. 36:133.
66. Suzuki, K., Tamaru, J., Okuyama, A. et al. 2010. IgG4-positive multi-organ lymphoproliferative syndrome manifesting as chronic symmetrical sclerosing dacryo-sialadenitis with subsequent secondary portal hypertension and remarkable IgG4-linked IL-4 elevation Rheumatology 49:1789.
67. Nakashima, H., Miyake, K., Moriyama, M. et al. 2010. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin. Nephrol. 73:385.
68. Tsuboi, H., Matsuo, N., Iizuka, M. et al. 2012. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res. Ther. 14:R171.
69. Jeannin, P., Lecoanet, S., Delneste, Y., Gauchat, J. F. and Bonnefoy, J. Y. 1998. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160:3555.
70. Maehara, T., Moriyama, M., Nakashima, H. et al. 2013. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Ann. Rheum. Dis. 71:2011.
71. Wojno, E. D. and Hunter, C. A. 2012. New directions in the basic and translational biology of interleukin-27. Trends Immunol. 33:91.
72. Banchereau, J., Pascual, V. and O'Garra, A. 2013. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat. Immunol. 13:925.
73. Apetoh, L., Quintana, F. J., Pot, C. et al. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11:854.
74. Kiyama, K., Kawabata, D., Hosono, Y. et al. 2012. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res. Ther. 14:R86.
75. Fukui, R. and Miyake, K. 2010. Controlling systems of nucleic acid sensing-TLRs restrict homeostatic inflammation. Exp. Cell Res. 318:1461.
76. Takeda, K. and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1.
77. Sutmuller, R. P., Morgan, M. E., Netea, M. G., Grauer, O. and Adema, G. J. 2006. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 27:387.
78. h2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49:3991.
79. Pot, C., Apetoh, L., Awasthi, A. and Kuchroo, V. K. 2011. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Semin. Immunol. 23:438.
80. Liu, G. and Zhao, Y. 2007. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122:149.
81. Kulkarni, R., Behboudi, S. and Sharif, S. 2011. Insights into the role of Toll-like receptors in modulation of T cell responses. Cell Tissue Res. 343:141.
82. He, B., Qiao, X. and Cerutti, A. 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173:4479.
83. Watanabe, T., Yamashita, K., Fujikawa, S. et al. 2012. Involvement of activation of toll-like receptors and nucleotidebinding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum. 64:914.
84. Watanabe, T., Yamashita, K., Sakurai, T. et al. 2013. Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J. Gastroenterol. 48:247.
85. Paul, W. E. and Zhu, J. 2010. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10:225.
86. Nagamachi, S., Ohsawa, I., Sato, N. et al. 2011. Immune complexmediated complement activation in a patient with IgG4-related tubulointerstitial nephritis. Case Rep. Nephrol. Urol. 1:7.
87. Kawano, M., Mizushima, I., Yamaguchi, Y. et al. 2012. Immunohistochemical characteristics of IgG4-related tubulointerstitial nephritis: detailed analysis of 20 Japanese cases. Int. J. Rheumatol. 2012:609795.
88. Muraki, T., Hamano, H., Ochi, Y. et al. 2006. Autoimmune pancreatitis and complement activation system. Pancreas 32:16.
89. Terness, P., Kohl, I., Hubener, G. et al. 1995. The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope. J. Immunol. 154:6446.
90. van de Stadt, L. A., Vrieze, H. D., Derksen, N. I. L. et al. 2014. Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antobody-mediated inflammation. Arthritis Rheumatol. 66:1133.
91. Hajishengallis, G. and Lambris, J. D. 2010. Crosstalk pathways between toll-like receptors and the complement system. Trends Immunol. 31:154.
92. Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C. and Kohl, J. 2005. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22:415.
93. Zen, Y. and Nakanuma, Y. 2010. IgG4-related disease: a crosssectional study of 114 cases. Am. J. Surg. Pathol. 34:1812.
94. Wynn, T. A. and Ramalingam, T. R. 2012. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18:1028.